Targeted Interventions for Weight-Concerned Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

October 31, 2009

Conditions
Nicotine Dependence
Interventions
DRUG

Naltrexone

Drug: Naltrexone 12.5 mg oral capsule once per day for 1 day then 25 mg oral capsule once per day for 27 weeks

DRUG

Transdermal nicotine replacement

Transdermal nicotine replacement (21 mg for first 6 weeks post-quit then 14 mg for 2 weeks) once per day + naltrexone 25 mg oral capsule once per day

BEHAVIORAL

Behavioral counseling

Brief behavioral counseling and research assessments are provided for two sessions prior to the quit date and then weekly for two weeks, bi-weekly for a month and every four weeks thereafter.

Trial Locations (1)

06511

Yale University School of Medicine Substance Abuse Treatment Unit, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT00105482 - Targeted Interventions for Weight-Concerned Smokers | Biotech Hunter | Biotech Hunter